Physician profile
Lisa Simons
NPI 1134118797
$612.57
in general payments reported to CMS, 2019-2025
12 companies · $57.71 in 2025
The $57.71 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $28.88 · 2021: $15.38 · 2022: $99.40 · 2023: $140 · 2024: $131 · 2025: $57.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $291 · Debt Forgiveness: $36.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.34 |
| Debt Forgiveness | $36.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $112.43 | 2019-2024 | Vaxelis, Gardasil 9, Gardasil |
| Tris Pharma INC | $101.68 | 2019-2025 | Quillivant, Onyda Xr |
| Cranial Technologies, INC | $85.71 | 2019-2023 | Doc Band |
| Sobi, INC | $70.54 | 2019-2023 | |
| Pfizer INC. | $67.44 | 2019-2024 | |
| Baxter Healthcare | $36.92 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $29.78 | 2024 | Flumist Quadrivalent |
| Sanofi Pasteur INC. | $25.53 | 2023 | |
| Sanofi-Aventis U.S. LLC | $25.48 | 2024 | |
| Ironshore Pharmaceuticals INC. | $21.11 | 2019 | |
| Galderma Laboratories, L.P. | $18.03 | 2022 | |
| Collegium Pharmaceutical, INC. | $17.92 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Simons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.